Creative Diagnostics offers Cellular Biosensors for the study of Ligand-Receptor Interactions which enable quantitative and kinetic real-time analysis of ligand binding and cell responses. Combining state of the art detection with stable and robust cell models, the biosensor systems are extremely sensitive, reproducible and stable. Applications of these systems are drug screening, signal transduction and receptor/ligand characterization, target validation, and high throughput discovery in drug and biomed discovery.
Talk to our experts Available Services
What is Cellular Biosensors for Ligand-Receptor Interaction?
Cell-based biosensors based on ligand-receptor interactions are specialized devices used to detect and measure the binding of molecules (ligands) to specific receptors on the surface of living cells. These biosensors, typically composed of living cells or cell assemblies integrated with sensitive detection elements, can monitor ligand-receptor interactions in real time. They provide valuable information on binding kinetics, affinity, and downstream cellular responses. Cell-based biosensors closely resemble the natural cellular environment, providing an ideal platform for studying ligand-receptor interactions. They are currently widely used in drug discovery, pharmacology, and biomedical research to investigate receptor activation, signal transduction pathways, and the effects of drugs on cellular processes.
Applications of Cellular Biosensors for Ligand-Receptor Interaction
- Drug discovery and screening
- Receptor pharmacology analysis
- Signal transduction pathway studies
- Target validation
- High-throughput screening
- Toxicity and efficacy testing
- Biomarker identification
- Therapeutic development and optimization
Why Choose Creative Diagnostics' Cellular Biosensors for Ligand-Receptor Interaction Services?
Creative Diagnostics offers Cellular Biosensors for Ligand-Receptor Interaction services. We have years of experience in cellular assay development, biosensor engineering, and detection technologies to support your study of molecular binding and cell signaling events. We can engineer a custom cellular biosensor platform to fit your research needs, whether it be real-time monitoring of interactions, binding affinity measurements, or signal transduction analyses. Our biosensor platforms are designed with optimal cell models, sensitive detection methods, and robust data analysis tools to ensure specificity, reproducibility, and biological relevance. We provide:
- A real-time monitoring platform based on living cells enables precise analysis of ligand-receptor binding kinetics.
- Highly sensitive signal detection technology ensures accurate identification of low-concentration ligands.
- Diverse cell models cover diverse receptor types and physiological environments.
- Optimized signal transduction assays reveal receptor activation and downstream pathway changes.
- High-throughput screening capabilities accelerate the discovery and validation of new drug targets.
- Strict quality control processes ensure data stability and reproducibility.
- Customized solutions meet our customers' diverse research and development needs.
- Comprehensive data analysis and interpretation support empowers scientific decision-making.
Get a Quote
Our Services
To meet the research and development demands for precise and reliable analysis of ligand-receptor interactions, we provide comprehensive Cellular Biosensors for Ligand-Receptor Interaction services. Employing a wide variety of cellular assay platforms, together with extremely sensitive detection systems, we facilitate reliable real-time measurements of binding and cellular responses. We provide optimized biosensor design and cell model selection, strict validation of assays, and numerous analytical tools (fluorescence resonance energy transfer (FRET), surface plasmon resonance (SPR), high-content imaging, label-free technologies etc.) for excellent sensitivity, specificity and biological relevance. This approach is broadly applicable in drug discovery, receptor pharmacology, signal transduction and drug development. Our extensive quality control procedures and vast experience in the technical knowledge assure each project of high reproducibility, stability and data consistency. Our core services include:
Chimeric Receptor Design and Construction
- Fusion of the extracellular domain of the target receptor with the transmembrane and intracellular signaling domains of a co-stimulatory receptor
- Develop chimeric receptors with robust signaling capabilities, ensuring sensitivity and specificity
High-efficiency Cell Line Development
- Use lentiviral transduction to generate reporter cells stably expressing the chimeric receptor
- Express the ligand in stimulatory cells via transient transfection or viral vectors
Co-culture Assays for Ligand-Receptor Interactions
- Co-culture stimulatory and reporter cells to activate reporter gene expression
- Quantitative analysis of receptor activation levels by flow cytometry
Blocker Efficacy Assessment
- Pre-incubate stimulatory cells with blocking agents, such as antibodies, fusion proteins, and small molecule inhibitors
- Measure the inhibitory effect of blocking agents on ligand-receptor binding and signaling
Data Acquisition and Analysis
- Provide detailed activation curves, binding kinetic parameters, and blocker efficacy reports
- Enable personalized data interpretation to assist in research decision-making
Cellular Biosensors for Ligand-Receptor Interaction Services Process
Design genes, construct expression systems, and produce chimeric receptors and ligands.
Establish reporter cells to detect ligand-receptor binding.
Co-culture cells to monitor signal activation in real time.
Ensure cell stability and accurate and reliable signals.
Analyze data, provide reports, and provide technical support.
Case Study

In the case study using the developed cellular biosensor to evaluate PD-1/PD-L1 immune checkpoint blockade, flow cytometry was used to assess the dose-response relationship between blocking antibody activation of the PD-1/PD-L1 interaction. The percentage of PD-1/PD-L1 interaction activation decreased significantly with increasing blocking antibody concentration, indicating that the antibody inhibited the interaction in a concentration-dependent manner. Data points represent the mean, and error bars represent the standard error. The horizontal axis is a logarithmic scale of antibody concentration.
FAQs About Cellular Biosensors for Ligand-Receptor Interaction Services
How do your cell-based biosensors ensure that the measured signal represents true ligand-receptor binding?
We use cell lines stably expressing chimeric receptors, combined with rigorous control experiments, to ensure specific and reliable signals and avoid false positives.
Can this cell-based biosensor be used for drug screening? How efficient is it?
Of course! Our platform supports high-throughput screening, enabling rapid and accurate identification of effective ligands or inhibitors, significantly reducing R&D time.
Can your technology detect weak-affinity ligand-receptor interactions?
Yes, our sensor design is highly sensitive, enabling us to capture low-affinity but biologically important interactions.
Can your cell-based biosensors be used to assess the blocking effect of antibodies or small molecules?
Yes! We first expose the blocking agent to the stimulated cells and then observe changes in signal intensity, allowing us to accurately measure blocking ability.
Can you customize a cell-based biosensor based on my research needs?
Of course. We have an experienced team that can design and build custom sensors tailored to your specific receptor or ligand needs.
Start Your Cellular Biosensors for Ligand-Receptor Interaction Study Services Project Today
To use our cellular biosensors for ligand-receptor interaction study services, please contact Creative Diagnostics, your expert immunology service provider. From research-scale cellular biosensors for ligand-receptor interaction study services to scale-up, our team is ready to support your R&D innovation.